TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

23.50$ +0.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow QURE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – -484.5% – – – – – -150.4% – – –
– +159.5% +25.4% +36.5% +49.4% -46.3% +59.7% -31.5% +17.0% +39.4% +6.2% +16.8%
– -27.5% -25.5% +63.0% +5.7% +63.7% +24.5% +17.4% +33.4% +2.6% -36.6% -20.6%
– +99.3% -65.5% +234.9% -75.4% +238.9% +98.4% -114.5% – – – –
– – -115.1% – – – – – – – -104.9% –
– -59.5% +82.4% -67.5% -24.0% +56.6% +42.7% +83.9% +1.4% -59.6% -52.9% -87.0%
– -62.5% +90.9% -65.4% -31.0% +56.6% +42.7% +610.5% +171.2% +12.6% – -297.4%
– – – – – – – – – – – –
– +89.1% -98.4% +3,396.2% +57.9% +73.8% -97.0% +334.8% – – – –
– -102.0% -20.4% – +0.0% +323.0% +0.0% +0.0% -100.0% – – -100.0%
– +78.1% -98.4% +3,584.0% +75.4% +57.5% -97.0% +1,174.3% -98.5% +25,001.8% -116.4% –
– +359.5% -154.2% – +180.9% +89.9% -192.8% – -205.3% – -729.8% –
– – -1,054.5% – – – – – -160.2% – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?